For: | Cheng Y, Desreumaux P. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol 2005; 11(3): 309-314 [PMID: 15637733 DOI: 10.3748/wjg.v11.i3.309] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/309.htm |
Number | Citing Articles |
1 |
A. Tursi, G. Brandimarte, W. Elisei, G.M. Giorgetti, C.D. Inchingolo, F. Aiello. Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease. Digestive and Liver Disease 2008; 40(9): 737 doi: 10.1016/j.dld.2008.02.022
|
2 |
Sandra Parenti, Lucia Montorsi, Sebastian Fantini, Fabiana Mammoli, Claudia Gemelli, Claudio Giacinto Atene, Lorena Losi, Chiara Frassineti, Bruno Calabretta, Enrico Tagliafico, Sergio Ferrari, Tommaso Zanocco-Marani, Alexis Grande. KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer Cells. Cancer Prevention Research 2018; 11(8): 503 doi: 10.1158/1940-6207.CAPR-17-0382
|
3 |
Rosivaldo S. Borges, Steven L. Castle. The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters 2015; 25(21): 4808 doi: 10.1016/j.bmcl.2015.07.001
|
4 |
H. E. Mukaya, E. W. Neuse, R. L. van Zyl, C. T. Chen. Synthesis and Preliminary Bio-evaluation of Polyaspartamide Co-conjugates of p-Amino-salicylic Acid Chelated Platinum(II) and Ferrocene Complexes. Journal of Inorganic and Organometallic Polymers and Materials 2015; 25(3): 367 doi: 10.1007/s10904-015-0174-9
|
5 |
Justin A. Maykel, Gonzalo Hagerman, Anders F. Mellgren, Shelby Y. Li, Karim Alavi, Nancy N. Baxter, Robert D. Madoff. Crohn's Colitis: The Incidence of Dysplasia and Adenocarcinoma in Surgical Patients. Diseases of the Colon & Rectum 2006; 49(7): 950 doi: 10.1007/s10350-006-0555-9
|
6 |
Richard H. Siggers, David J. Hackam. The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases. Cellular and Molecular Life Sciences 2011; 68(22): 3623 doi: 10.1007/s00018-011-0821-4
|
7 |
Dawn M. Torres, Stephen A. Harrison. Hepatitis C, insulin resistance, and steatosis. Current Hepatitis Reports 2007; 6(4): 129 doi: 10.1007/s11901-007-0015-6
|
8 |
Jyothi S. Prabhu, Aruna Korlimarla, Arindam Banerjee, Shivangi Wani, K Payal, Rashmita Sahoo. Gene-Specific Methylation: Potential Markers for Colorectal Cancer. The International Journal of Biological Markers 2009; 24(1): 57 doi: 10.1177/172460080902400109
|
9 |
Jeffrey Tang, Omar Sharif, Chetan Pai, Ann L. Silverman. Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2010; 55(6): 1696 doi: 10.1007/s10620-009-0942-x
|
10 |
Rosa Ana Risques, Lisa A. Lai, Cigdem Himmetoglu, Anoosheh Ebaee, Lin Li, Ziding Feng, Mary P. Bronner, Bassel Al-Lahham, Kris V. Kowdley, Keith D. Lindor, Peter S. Rabinovitch, Teresa A. Brentnall. Ulcerative Colitis–Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and Inflammation. Cancer Research 2011; 71(5): 1669 doi: 10.1158/0008-5472.CAN-10-1966
|
11 |
Michael Quante, Julian A. Abrams, Yoomi Lee, Timothy C. Wang. Barrett esophagus. Cell Cycle 2012; 11(23): 4328 doi: 10.4161/cc.22485
|
12 |
Chunyi Wang, Zhongxue Fu. The study of RNAi-mediated by conditionally replicating adenovirus silencing on Survivin gene in colon cancer cell lastingly. The Chinese-German Journal of Clinical Oncology 2008; 7(8): 460 doi: 10.1007/s10330-008-0061-8
|
13 |
Pamela M. OʼConnor, Tamia K. Lapointe, Paul L. Beck, Andre G. Buret. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(8): 1411 doi: 10.1002/ibd.21217
|
14 |
Lorne J. Hofseth, Lei Ying. Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2006; 1765(1): 74 doi: 10.1016/j.bbcan.2005.08.005
|
15 |
Peter Laszlo Lakatos, Laszlo Lakatos. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World Journal of Gastroenterology 2008; 14(25): 3937-3947 doi: 10.3748/wjg.14.3937
|
16 |
Vikrant Sibartie, Brian Feagan. Clinical Dilemmas in Inflammatory Bowel Disease. 2006; : 25 doi: 10.1002/9780470750827.ch8
|
17 |
Tae Kyung Ha, Ji Yeong An, Ho Geun Youn, Jae Hyung Noh, Tae Sung Sohn, Sung Kim. Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric Cancer. Yonsei Medical Journal 2007; 48(6): 981 doi: 10.3349/ymj.2007.48.6.981
|
18 |
Tomomitsu Tahara, Tomoyuki Shibata, Masaaki Okubo, Tomohiko Kawamura, Noriyuki Horiguchi, Takamitsu Ishizuka, Naoko Nakano, Mitsuo Nagasaka, Yoshihito Nakagawa, Naoki Ohmiya. Demonstration of potential link between Helicobacter pylori related promoter CpG island methylation and telomere shortening in human gastric mucosa. Oncotarget 2016; 7(28): 43989 doi: 10.18632/oncotarget.9764
|
19 |
Muhammad Y. Sheikh. Steatosis in hepatitis C: Mechanisms and basic concepts. Current Hepatitis Reports 2008; 7(4): 152 doi: 10.1007/s11901-008-0030-2
|
20 |
Lauriane Onfroy-Roy, Dimitri Hamel, Laurent Malaquin, Audrey Ferrand. Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?. Cancers 2021; 13(8): 1749 doi: 10.3390/cancers13081749
|
21 |
S. PARENTI, F. FERRARINI, R. ZINI, M. MONTANARI, L. LOSI, B. CANOVI, S. FERRARI, A. GRANDE. Mesalazine inhibits the β‐catenin signalling pathway acting through the upregulation of μ‐protocadherin gene in colo‐rectal cancer cells. Alimentary Pharmacology & Therapeutics 2010; 31(1): 108 doi: 10.1111/j.1365-2036.2009.04149.x
|
22 |
Hajjaj H.M. Abdu-Allah, Samia G. Abdel-Moty, Raafat El-Awady, Abdel-Nasser A. El-Shorbagi. Design and synthesis of novel 5-aminosalicylate (5-ASA)–4-thiazolinone hybrid derivatives with promising antiproliferative activity. Bioorganic & Medicinal Chemistry Letters 2016; 26(7): 1647 doi: 10.1016/j.bmcl.2016.02.073
|
23 |
F. Holzinger, D. Giachino, E. Karamitopoulou-Diamantis, S. Birrer. Unerwarteter, intraoperativer Befund im Bereiche des distalen Ösophagus. Der Chirurg 2007; 78(6): 548 doi: 10.1007/s00104-006-1248-6
|
24 |
Ad A van Bodegraven, Chris JJ Mulder. Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete?. World Journal of Gastroenterology 2006; 12(38): 6115-6123 doi: 10.3748/wjg.v12.i38.6115
|
25 |
Tomomitsu Tahara, Tomoyuki Shibata, Tomohiko Kawamura, Takamitsu Ishizuka, Masaaki Okubo, Mitsuo Nagasaka, Yoshihito Nakagawa, Tomiyasu Arisawa, Naoki Ohmiya, Ichiro Hirata. Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use. Clinical and Experimental Medicine 2016; 16(1): 65 doi: 10.1007/s10238-014-0335-0
|
26 |
|
27 |
Vijay L. Kumar, Sneh Verma, Prasenjit Das. Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer. Drug Development Research 2019; 80(8): 1089 doi: 10.1002/ddr.21590
|
28 |
M. Schwab, V. Reynders, S. Loitsch, Y. M. Shastri, D. Steinhilber, O. Schroder, J. Stein. PPAR is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis 2008; 29(7): 1407 doi: 10.1093/carcin/bgn118
|
29 |
XIAOTAN DOU, JUNHUA XIAO, ZILIANG JIN, PING ZHENG. Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia. Oncology Letters 2015; 10(3): 1259 doi: 10.3892/ol.2015.3397
|
30 |
Peri Newman, Joshua Muscat. Potential Role of Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention for Inflammatory Bowel Disease: An Umbrella Review. Cancers 2023; 15(4): 1102 doi: 10.3390/cancers15041102
|
31 |
Mariëlle Romberg-Camps, Edith Kuiper, Leo Schouten, Arnold Kester, Martine Hesselink-van de Kruijs, Charles Limonard, Rens Bos, Jelle Goedhard, Wim Hameeteman, Frank Wolters, Maurice Russel, Reinhold Stockbrügger, Pieter Dagnelie. Mortality in inflammatory bowel disease in the Netherlands 1991–2002. Inflammatory Bowel Diseases 2010; 16(8): 1397 doi: 10.1002/ibd.21189
|
32 |
Roufaida Merir, Milad Baitiche, Zineb Elbahri, Riadh Bourzami, Ferhat Djerboua, Mokhtar Boutahala. Conception of Cellulose/Alginate/Mesalazine microspheres by solvent evaporation technique for drug release: Experimental and theoretical investigations. International Journal of Biological Macromolecules 2023; 243: 124894 doi: 10.1016/j.ijbiomac.2023.124894
|
33 |
Fumito Saijo, Alexandra B. Milsom, Nathan S. Bryan, Selena M. Bauer, Thorsten Vowinkel, Marina Ivanovic, Chris Andry, D. Neil Granger, Juan Rodriguez, Martin Feelisch. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide 2010; 22(2): 155 doi: 10.1016/j.niox.2009.11.009
|
34 |
Antonio Tursi, Giovanni Brandimarte, Walter Elisei, Cosimo Damiano Inchingolo, Fabio Aiello. Epithelial Cell Proliferation of the Colonic Mucosa in Different Degrees of Colonic Diverticular Disease. Journal of Clinical Gastroenterology 2006; 40(4): 306 doi: 10.1097/01.mcg.0000210093.54425.72
|
35 |
Christopher D. Jahraus, David T. Rubin, Ellen J. Scherl, Doug Bettenhausen. Inflammation’s Role in Rectal Cancer Following Prostate Radiotherapy, and Emerging Evidence for a Protective Role for Balsalazide. Gastroenterology 2005; 129(2): 770 doi: 10.1053/j.gastro.2005.06.042
|
36 |
Tomomitsu Tahara, Tomoyuki Shibata, Masaaki Okubo, Tomohiko Kawamura, Kazuya Sumi, Takamitsu Ishizuka, Masakatsu Nakamura, Mitsuo Nagasaka, Yoshihito Nakagawa, Naoki Ohmiya, Tomiyasu Arisawa, Ichiro Hirata. Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypes. Clinical and Experimental Medicine 2015; 15(3): 327 doi: 10.1007/s10238-014-0295-4
|
37 |
Shaji Sebastian, Vincent Hernández, Pär Myrelid, Revital Kariv, Epameinondas Tsianos, Murat Toruner, Marc Marti-Gallostra, Antonino Spinelli, Andrea E. van der Meulen-de Jong, Elif Sarıtas Yuksel, Christoph Gasche, Sandro Ardizzone, Silvio Danese. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I). Journal of Crohn's and Colitis 2014; 8(1): 5 doi: 10.1016/j.crohns.2013.04.008
|
38 |
S Nikolaus, S Schreiber, B Siegmund, B Bokemeyer, E Bästlein, O Bachmann, D Görlich, U Hofmann, M Schwab, W Kruis. Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence. Journal of Crohn's and Colitis 2017; 11(9): 1052 doi: 10.1093/ecco-jcc/jjx062
|
39 |
Mehmet Yalchin, Ann-Marie Baker, Trevor A. Graham, Ailsa Hart. Predicting Colorectal Cancer Occurrence in IBD. Cancers 2021; 13(12): 2908 doi: 10.3390/cancers13122908
|
40 |
Milad Moradi, Elnaz Mazaher Haji Agha, Salar Hemmati, Fleming Martinez, Martin Kuentz, Abolghasem Jouyban. Solubility of 5-aminosalicylic acid in {N-methyl-2-pyrrolidone + ethanol} mixtures at T = (293.2 to 313.2) K. Journal of Molecular Liquids 2020; 306: 112774 doi: 10.1016/j.molliq.2020.112774
|
41 |
Enzyme Catalyzed Synthesis of Water Soluble Mesalazine Oligomers and Evaluation of their Efficiency in Polypropylene Stabilization. Polymer Science, Series B 2021; 63(6): 710 doi: 10.1134/S1560090421060051
|
42 |
Yohei Shirakami, Takahiro Kochi, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Kazuto Yoshimi, Takashi Kuramoto, Takuji Tanaka, Masahito Shimizu, Mitsuru Seishima. Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon. Oncotarget 2018; 9(74): 33972 doi: 10.18632/oncotarget.26119
|
43 |
S. Viennot, A. Deleporte, D. Moussata, S. Nancey, B. Flourié, J.-M. Reimund. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroentérologie Clinique et Biologique 2009; 33: S190 doi: 10.1016/S0399-8320(09)73154-9
|
44 |
S. Morini, C. Hassan, A. Zullo, V. De Francesco, O. Burattini, M. Margiotta, C. Panella, E. Ierardi. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case–control study. Alimentary Pharmacology & Therapeutics 2005; 21(11): 1385 doi: 10.1111/j.1365-2036.2005.02492.x
|